ArticleNeurology and therapy2026

Characteristics and Hospitalization Details of Patients with Advanced Parkinson's Disease Receiving Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa: Real-World First-Year Descriptive Study from Japan.

Toru Baba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.